ADAM17 and metastatic neoplasm: Since ADAM17 is constitutively expressed by the majority of the cellular components of the TME (33), cleaved mbIL-15 activates enzymatic activity and the transcription of ADAM17 on a very broad cellular spectrum that amplifies the IL-15/ADAM17 loop, thus generating an important immune escape mechanism in the metastatic tumors.